These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 647158)
1. The uptake and release of [3-H]-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthlane (ADTN) by striatal nerve terminals. Davis A; Roberts PJ; Woodruff GN Br J Pharmacol; 1978 May; 63(1):183-90. PubMed ID: 647158 [TBL] [Abstract][Full Text] [Related]
2. Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices. Mulder AH; Braakhuis B; De Regt V; Dijkstra D; Horn AS Eur J Pharmacol; 1980 Jun; 64(4):349-55. PubMed ID: 7389827 [TBL] [Abstract][Full Text] [Related]
3. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes. Bowyer JF; Spuhler KP; Weiner N J Pharmacol Exp Ther; 1984 Jun; 229(3):671-80. PubMed ID: 6726652 [TBL] [Abstract][Full Text] [Related]
4. ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene): a prototype for possible dopaminergic false transmitters? Roberts PJ; Davis A Adv Biochem Psychopharmacol; 1978; 19():177-91. PubMed ID: 696460 [No Abstract] [Full Text] [Related]
5. Selective storage in vivo of 5,6-ADTN in dopamine-rich areas of the rat brain. Westerink BH; Dijkstra D; Feenstra MG; Horn AS; Rollema H Eur J Pharmacol; 1980 Jun; 64(2-3):115-21. PubMed ID: 7398758 [TBL] [Abstract][Full Text] [Related]
6. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand. Clement-Cormier Y; Abel M Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes. Bowyer JF; Masserano JM; Weiner N J Pharmacol Exp Ther; 1987 Jan; 240(1):177-86. PubMed ID: 3100768 [TBL] [Abstract][Full Text] [Related]
8. Phorbol esters potentiate rapid dopamine release from median eminence and striatal synaptosomes. Shu C; Selmanoff M Endocrinology; 1988 Jun; 122(6):2699-709. PubMed ID: 3131121 [TBL] [Abstract][Full Text] [Related]
9. Evidence for a similar compartmentation of recaptured and endogenously synthesized dopamine in striatal synaptosomes. Cerrito F; Casazza G; Levi G; Raiteri M Neurochem Res; 1980 Feb; 5(2):115-21. PubMed ID: 7366797 [TBL] [Abstract][Full Text] [Related]
10. Comparative effects of benztropine and nomifensine on dopamine uptake and release from striatal synaptosomes. McKillop D; Bradford HF Biochem Pharmacol; 1981 Oct; 30(20):2753-8. PubMed ID: 7317073 [No Abstract] [Full Text] [Related]
11. Release of dopamine from striatal synaptosomes. Raiteri M; Cerrito F; Cervoni AM; Del Carmine R; Ribera MT; Levi G Ann Ist Super Sanita; 1978; 14(1):97-110. PubMed ID: 227308 [TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter mediated release of dopamine: role of chloride. Sitges M; Reyes A; Chiu LM J Neurosci Res; 1994 Sep; 39(1):11-22. PubMed ID: 7807588 [TBL] [Abstract][Full Text] [Related]
13. The accumulation of dopamine into striatal synaptosomes, and its inhibition: comparison of crude, partially purified and purified synaptosomal preparations. Tuomisto J; Tuomisto L Med Biol; 1979 Aug; 57(4):238-45. PubMed ID: 513880 [No Abstract] [Full Text] [Related]
14. Kinetics of dopamine and noradrenaline transport in synaptosomes from cerebellum, striatum and frontal cortex of normal and reeler mice. Efthimiopoulos S; Giompres P; Valcana T J Neurosci Res; 1991 Aug; 29(4):510-9. PubMed ID: 1838778 [TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor binding of 3H-ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) regulated by guanyl nucleotides. Creese I; Snyder SH Eur J Pharmacol; 1978 Aug; 50(4):459-61. PubMed ID: 699970 [No Abstract] [Full Text] [Related]
16. Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum. Ross SB; Kelder D Acta Pharmacol Toxicol (Copenh); 1979 May; 44(5):329-35. PubMed ID: 474143 [TBL] [Abstract][Full Text] [Related]
17. Evidence for a functional coupling between dopamine reuptake and tyrosine hydroxylation in striatal nerve terminals. Maura G; Raiteri M Neurochem Int; 1982; 4(4):225-31. PubMed ID: 20487872 [TBL] [Abstract][Full Text] [Related]
18. Inhibitors of arachidonic acid metabolism: effects on rat striatal dopamine release and uptake. Cass WA; Larson G; Fitzpatrick FA; Zahniser NR J Pharmacol Exp Ther; 1991 Jun; 257(3):990-6. PubMed ID: 1828506 [TBL] [Abstract][Full Text] [Related]
19. Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? Raiteri M; Bonanno G; Marchi M; Maura G J Pharmacol Exp Ther; 1984 Dec; 231(3):671-7. PubMed ID: 6150107 [TBL] [Abstract][Full Text] [Related]
20. Comparison of uptake of dopamine in rat striatal chopped tissue and synaptosomes. Near JA; Bigelow JC; Wightman RM J Pharmacol Exp Ther; 1988 Jun; 245(3):921-7. PubMed ID: 3385647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]